Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...

Portable screen-printed carbon electrode (SPCE) biosensors offer a rapid and low-cost way to detect microcystin-lysine-arginine (MC-LR), an extremely potent toxin produced by cyanobacteria during ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection ...

Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...

Artificial Intelligence is transforming GI endoscopy by improving detection accuracy, enhancing diagnosis, and supporting ...